Department of Joint Surgery, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China (mainland).
School of Materials and Energy, Southwest University; Southwest University Hospital, Chongqing, China (mainland).
Med Sci Monit. 2023 Sep 16;29:e940805. doi: 10.12659/MSM.940805.
Tendon-bone injuries are a prevalent health concern associated with sports and other physically demanding activities. These injuries have a limited innate healing ability, often leading to the formation of scar tissue rather than the regeneration of healthy tendon tissue. This scar tissue results from excessive fibrosis during the early healing process and often leads to reduced tendon function and an increased risk of reinjury. Traditionally, surgical reconstruction has been the primary treatment for tendon-bone injuries. However, restoring the natural structure and mechanical properties of tendons after surgical reconstruction presents a considerable challenge. Recently, the potential of stem cell therapy has been explored as an alternative treatment approach. In particular, a new type of pluripotent stem cell known as tendon stem cells (TDSCs) has been identified within tendon tissue. These cells exhibit the potential for self-renewal and multidirectional differentiation, meaning they can differentiate into fibroblasts and chondrocytes. These differentiated cells can aid in the repair and regeneration of new tissues by producing collagen and other matrix molecules that provide structural support. TDSCs have become a focal point in research for treating tendon-bone injuries and related conditions. The potential use of these cells provides a basis for both basic research and clinical applications, particularly in understanding the tendon-bone healing process and identifying factors that affect the ability of TDSCs to promote this healing. This review article aims to analyze the role of TDSCs in tendon-bone healing, understanding their therapeutic potential and contributing to the development of effective treatment strategies for tendon-bone injuries.
肌腱骨损伤是与运动和其他体力活动相关的普遍健康问题。这些损伤的内在愈合能力有限,往往导致形成疤痕组织,而不是健康肌腱组织的再生。这种疤痕组织是由于早期愈合过程中过度纤维化引起的,往往导致肌腱功能降低和再次受伤的风险增加。传统上,手术重建是治疗肌腱骨损伤的主要方法。然而,在手术重建后恢复肌腱的自然结构和机械性能是一个相当大的挑战。最近,干细胞治疗的潜力已被探索作为一种替代治疗方法。特别是,在肌腱组织中发现了一种新型多能干细胞,称为肌腱干细胞(TDSCs)。这些细胞表现出自我更新和多向分化的潜力,这意味着它们可以分化为成纤维细胞和软骨细胞。这些分化细胞可以通过产生胶原蛋白和其他提供结构支撑的基质分子来帮助修复和再生新组织。TDSCs 已成为治疗肌腱骨损伤和相关疾病的研究焦点。这些细胞的潜在用途为基础研究和临床应用提供了基础,特别是在了解肌腱骨愈合过程和确定影响 TDSCs 促进这种愈合能力的因素方面。本文旨在分析 TDSCs 在肌腱骨愈合中的作用,了解其治疗潜力,并为肌腱骨损伤的有效治疗策略的发展做出贡献。